Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064935 · ClinicalTrials.gov registry record · Phase 3
Endometrial Biopsy in Infertile Patients
A Phase 3 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 3
- Development phase
- 880
- Enrollment target
NCT00064935 is a Phase 3 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 880 participants.
The verdict
NCT00064935, a Phase 3 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 880 participants
- Enrollment target
Study Summary
When a woman becomes pregnant, the fertilized egg attaches itself to the lining of the uterus (endometrium). The endometrium is constantly changing throughout a woman's menstrual cycle in response to the female hormones estrogen and progesterone. The endometrium must have certain characteristics (be at a specific phase in its cycle) in order for the fertilized egg to successfully attach. Infertility may be caused by an "out of phase" endometrium (i.e., the endometrium doesn't have the right characteristics when the fertilized egg reaches it). The purpose of this study is to evaluate whether the endometrial biopsy is useful in predicting the potential for becoming pregnant and bearing a child.
Interventions
- PROCEDURE Endometrial biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 880 participants |
| Start Date | 1999-04 |
| Est. Completion | 2002-02 |
| Phase | Phase 3 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00064935
The ClinicalTrials.gov registry entry for NCT00064935 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 880 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endometrial biopsy is the first listed.
NCT00064935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00064935 about?
NCT00064935 is a clinical study titled "Endometrial Biopsy in Infertile Patients". When a woman becomes pregnant, the fertilized egg attaches itself to the lining of the uterus (endometrium). The endometrium is constantly changing throughout a woman's menstrual cycle in response to the female hormones estrogen and progesterone. The endometrium must have certain characteristics (be...
What is the current status of trial NCT00064935?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 880 participants. The study started on 1999-04. Estimated completion is 2002-02.
What interventions are being tested in trial NCT00064935?
The interventions under investigation include: Endometrial biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00064935?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.